215 related articles for article (PubMed ID: 31805977)
1. NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2.
Xu P; Ye S; Li K; Huang M; Wang Q; Zeng S; Chen X; Gao W; Chen J; Zhang Q; Zhong Z; Lin Y; Rong Z; Xu Y; Hao B; Peng A; Ouyang M; Liu Q
J Exp Clin Cancer Res; 2019 Dec; 38(1):483. PubMed ID: 31805977
[TBL] [Abstract][Full Text] [Related]
2. S-Nitrosylation of Histone Deacetylase 2 by Neuronal Nitric Oxide Synthase as a Mechanism of Diastolic Dysfunction.
Yoon S; Kim M; Lee H; Kang G; Bedi K; Margulies KB; Jain R; Nam KI; Kook H; Eom GH
Circulation; 2021 May; 143(19):1912-1925. PubMed ID: 33715387
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NOS1 promotes the interferon response of melanoma cells.
Chen X; Zou Z; Wang Q; Gao W; Zeng S; Ye S; Xu P; Huang M; Li K; Chen J; Zhong Z; Zhang Q; Hao B; Liu Q
J Transl Med; 2022 May; 20(1):205. PubMed ID: 35538490
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression.
Xu P; Xiong W; Lin Y; Fan L; Pan H; Li Y
Cell Death Dis; 2021 Aug; 12(8):779. PubMed ID: 34365463
[TBL] [Abstract][Full Text] [Related]
5. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.
Wang Y; Zhang J; Wu L; Liu W; Wei G; Gong X; Liu Y; Ma Z; Ma F; Thiery JP; Chen L
Breast Cancer Res; 2018 Aug; 20(1):83. PubMed ID: 30071870
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
[TBL] [Abstract][Full Text] [Related]
7. A GAPDH-mediated trans-nitrosylation pathway is required for feedback inhibition of bile salt synthesis in rat liver.
Rodríguez-Ortigosa CM; Celay J; Olivas I; Juanarena N; Arcelus S; Uriarte I; Marín JJ; Avila MA; Medina JF; Prieto J
Gastroenterology; 2014 Nov; 147(5):1084-93. PubMed ID: 25066374
[TBL] [Abstract][Full Text] [Related]
8. Melanoma NOS1 expression promotes dysfunctional IFN signaling.
Liu Q; Tomei S; Ascierto ML; De Giorgi V; Bedognetti D; Dai C; Uccellini L; Spivey T; Pos Z; Thomas J; Reinboth J; Murtas D; Zhang Q; Chouchane L; Weiss GR; Slingluff CL; Lee PP; Rosenberg SA; Alter H; Yao K; Wang E; Marincola FM
J Clin Invest; 2014 May; 124(5):2147-59. PubMed ID: 24691438
[TBL] [Abstract][Full Text] [Related]
9. The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line.
Badgwell B; Lesinski GB; Magro C; Abood G; Skaf A; Carson W
J Surg Res; 2004 Jan; 116(1):129-36. PubMed ID: 14732359
[TBL] [Abstract][Full Text] [Related]
10. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.
Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park H; Lee JY; Nam SW
J Cell Biochem; 2012 Jun; 113(6):2167-77. PubMed ID: 22492270
[TBL] [Abstract][Full Text] [Related]
11. Targeted inactivation of HDAC2 restores p16INK4a activity and exerts antitumor effects on human gastric cancer.
Kim JK; Noh JH; Eun JW; Jung KH; Bae HJ; Shen Q; Kim MG; Chang YG; Kim SJ; Park WS; Lee JY; Borlak J; Nam SW
Mol Cancer Res; 2013 Jan; 11(1):62-73. PubMed ID: 23175521
[TBL] [Abstract][Full Text] [Related]
12. Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).
Chawla-Sarkar M; Leaman DW; Jacobs BS; Tuthill RJ; Chatterjee-Kishore M; Stark GR; Borden EC
J Interferon Cytokine Res; 2002 May; 22(5):603-13. PubMed ID: 12060499
[TBL] [Abstract][Full Text] [Related]
13. S-nitrosylation of HDAC2 regulates the expression of the chromatin-remodeling factor Brm during radial neuron migration.
Nott A; Nitarska J; Veenvliet JV; Schacke S; Derijck AA; Sirko P; Muchardt C; Pasterkamp RJ; Smidt MP; Riccio A
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):3113-8. PubMed ID: 23359715
[TBL] [Abstract][Full Text] [Related]
14. Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes.
Testoni B; Durantel D; Lebossé F; Fresquet J; Helle F; Negro F; Donato MF; Levrero M; Zoulim F
Gut; 2016 Apr; 65(4):672-82. PubMed ID: 26082258
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interferon-gamma-stimulated melanoma progression by targeting neuronal nitric oxide synthase (nNOS).
Tong S; Cinelli MA; El-Sayed NS; Huang H; Patel A; Silverman RB; Yang S
Sci Rep; 2022 Feb; 12(1):1701. PubMed ID: 35105915
[TBL] [Abstract][Full Text] [Related]
16. Interferon Alpha Signalling and Its Relevance for the Upregulatory Effect of Transporter Proteins Associated with Antigen Processing (TAP) in Patients with Malignant Melanoma.
Heise R; Amann PM; Ensslen S; Marquardt Y; Czaja K; Joussen S; Beer D; Abele R; Plewnia G; Tampé R; Merk HF; Hermanns HM; Baron JM
PLoS One; 2016; 11(1):e0146325. PubMed ID: 26735690
[TBL] [Abstract][Full Text] [Related]
17. STAT5 contributes to interferon resistance of melanoma cells.
Wellbrock C; Weisser C; Hassel JC; Fischer P; Becker J; Vetter CS; Behrmann I; Kortylewski M; Heinrich PC; Schartl M
Curr Biol; 2005 Sep; 15(18):1629-39. PubMed ID: 16169484
[TBL] [Abstract][Full Text] [Related]
18. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2.
Leaman DW; Chawla-Sarkar M; Jacobs B; Vyas K; Sun Y; Ozdemir A; Yi T; Williams BR; Borden EC
J Interferon Cytokine Res; 2003 Dec; 23(12):745-56. PubMed ID: 14769151
[TBL] [Abstract][Full Text] [Related]
19. Difference of interferon-α and interferon-β on melanoma growth and lymph node metastasis in mice.
Roh MR; Zheng Z; Kim HS; Jeung HC; Rha SY; Chung KY
Melanoma Res; 2013 Apr; 23(2):114-24. PubMed ID: 23358428
[TBL] [Abstract][Full Text] [Related]
20. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
